These results suggest that GIGYF2 functions as a positive regulator of STAU1, which in turn upregulates PTEN expression, ultimately leading to PI3K/AKT pathway inactivation and hepatic insulin resistance. This evidence concerns the gene GIGYF2 and Insulin resistance.